Show simple item record

dc.contributor.authorHeltne, Marianne
dc.contributor.authorSaltvedt, Ingvild
dc.contributor.authorLydersen, Stian
dc.contributor.authorPrestmo, Anders
dc.contributor.authorSletvold, Olav
dc.contributor.authorSpigset, Olav
dc.date.accessioned2018-01-24T08:33:47Z
dc.date.available2018-01-24T08:33:47Z
dc.date.created2017-08-08T15:31:55Z
dc.date.issued2017
dc.identifier.citationEuropean Journal of Clinical Pharmacology. 2017, 73 (8), 937-947.nb_NO
dc.identifier.issn0031-6970
dc.identifier.urihttp://hdl.handle.net/11250/2479241
dc.description.abstractPurpose In the Trondheim Hip Fracture Trial, 397 home-dwelling patients with hip fractures were randomised to comprehensive geriatric care (CGC) in a geriatric ward or traditional orthopaedic care (OC). Patients in the CGC group had significantly better mobility and function 4 months after discharge. This study explores group differences in drug prescribing and possible associations with the outcomes in the main study. Methods Drugs prescribed at admission and discharge were registered from hospital records. Mobility, function, fear of falling and quality of life were assessed using specific rating scales. Linear regression was used to analyse association between drug changes and outcomes at 4 months. Results The mean age was 83 years, and 74% were females. The mean number (± SD) of drugs in the CGC and OC groups was 3.8 (2.8) and 3.9 (2.8) at inclusion and 7.1 (2.8) and 6.2 (3.0) at discharge, respectively (p = 0.003). The total number of withdrawals was 209 and 82 in the CGC and OC groups, respectively (p < 0.0001), and the number of starts was 844 and 526, respectively (p < 0.0001). A significant negative association was found between the number of drug changes during the hospital stay and mobility and function 4 months later in both groups. However, this association disappeared when adjusting for baseline function and comorbidities. Conclusion These secondary analyses suggest that there are significant differences in the pharmacological treatment between geriatric and orthopaedic wards, but these differences could not explain the beneficial effect of CGC in the Trondheim Hip Fracture Trial.nb_NO
dc.language.isoengnb_NO
dc.publisherSpringer Verlagnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titlePatterns of drug prescriptions in an orthogeriatric ward as compared to orthopaedic ward: results from the Trondheim Hip Fracture Trial - a randomised clinical trialnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber937-947nb_NO
dc.source.volume73nb_NO
dc.source.journalEuropean Journal of Clinical Pharmacologynb_NO
dc.source.issue8nb_NO
dc.identifier.doi10.1007/s00228-017-2263-x
dc.identifier.cristin1484957
dc.description.localcode© The Author(s) 2017. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)nb_NO
cristin.unitcode194,65,30,0
cristin.unitcode194,65,35,5
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for nevromedisin og bevegelsesvitenskap
cristin.unitnameRKBU Midt-Norge - Regionalt kunnskapssenter for barn og unge - psykisk helse og barnevern
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.fulltextoriginal
cristin.qualitycode2


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal